U.S. market Closed. Opens in 3 hours 42 minutes

AMED | Amedisys, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for AMED we got that it has average fundamentals where Valuation is considered to be slightly undervalued, Profitability is poor, Growth is on medium level and Health is passable.

Valuation (66%)

Company Industry
P/E Ratio (TTM) 28.38 28.17
PEG Ratio (TTM) 0.00 -0.78
P/S Ratio (TTM) 1.39 1.71
P/B Ratio (TTM) 2.83 2.51
P/FCF Ratio (TTM) 35.98 14.89
Price to 5YR AVG Earnings Ratio 25.14 22.20
Price to 5YR AVG FCF Ratio 17.48 21.36

Profitability (45%)

Company Industry
ROA (TTM) 5.29% 2.74%
ROE (TTM) 10.37% 29.50%
Net Profit Margin (TTM) 4.89% -1.89%
ROIC 5YR AVG 16.07% 16.57%

Growth (53%)

4QTR AVG 3YR AVG 5YR AVG
EPS 61.28% 21.65% -17.27%
Revenue 1.69% 10.15% 6.29%
Net Income 61.23% 21.64% -17.32%
Cash Flow 346.33% -0.40% -5.54%

Health (58%)

Company Industry
Current Ratio (TTM) 1.16 1.37
Quick Ratio (TTM) 1.16 1.21
D/E Ratio (TTM) 0.37 1.91
Interest Coverage (TTM) 12.19 16.10
Piotroski F-Score 3 7
Altman Z-Score 3.93 2.81
LTL to 5YR AVG FCF 1.90 7.48
Shares Outstanding Growth 5YR AVG -0.11% 20.92%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙